British Regulator Declares Cannabis Compound A Medicine

Last Thursday the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) officially announced it was designating cannabidiol (CBD) – a non-psychoactive cannabis compound – as a medicine that can be administered for the purpose of “restoring, correcting, or modifying physiological functions.” This means that CBD products, which British law has been silent on until […]

Read More

Kentucky: University Part Of First Study On Marijuana Compound Effects

Addiction researchers are only beginning to understand how dozens of chemical compounds found in the marijuana plant, known as cannabinoids, influence human health and behavior. According to Shanna Babalonis, a researcher and assistant professor of behavioral science at the University of Kentucky, research investigating the effects of cannabinoids on humans is limited. The well-known marijuana […]

Read More

Kentucky: University Part Of First Study On Marijuana Compound Effects

Addiction researchers are only beginning to understand how dozens of chemical compounds found in the marijuana plant, known as cannabinoids, influence human health and behavior. According to Shanna Babalonis, a researcher and assistant professor of behavioral science at the University of Kentucky, research investigating the effects of cannabinoids on humans is limited. The well-known marijuana […]

Read More

Medical Marijuana Inc Announces Positive Developments in Recent Studies Using Cannabidiol (CBD) Compound.

Medical Marijuana IncAnnounces Positive Developments in Recent Studies Using Cannabidiol (CBD) Compound; NBC News, ABC News and Huffington Post Report California Pacific Medical Center’s Findings That CBD Stops Metastasis in Aggressive Cancers SAN DIEGO, Calif. — Medical Marijuana Inc. (MJNA) is pleased to inform shareholders and the general public of recent developments in the research […]

Read More